{{cart_num}}
My CartCAS：78110-38-0
Molecular Formula：C13H17N5O8S2
Molecular Weight：435.43
Storage：Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year
Purity：HPLC≥98%
Appearance：White to off-white Solid
Qty：
Size：
| CAS | 78110-38-0 |
| Name | Aztreonam |
| Molecular Formula | C13H17N5O8S2 |
| Molecular Weight | 435.43 |
| Solubility | Soluble in DMSO ≥5mg/mL |
| Purity | HPLC≥98% |
| Appearance | White to off-white Solid |
| Storage | Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year |
| EC | EINECS 278-839-9 |
| MDL | MFCD00072145 |
| SMILES | CC(C)(O/N=C(C1=CSC(N)=N1)\C(N[C@H]2[C@H](C)N(S(=O)(O)=O)C2=O)=O)C(O)=O |
| InChIKey | WZPBZJONDBGPKJ-VEHQQRBSSA-N |
| InChI | InChI=1S/C13H17N5O8S2/c1-5-7(10(20)18(5)28(23,24)25)16-9(19)8(6-4-27-12(14)15-6)17-26-13(2,3)11(21)22/h4-5,7H,1-3H3,(H2,14,15)(H,16,19)(H,21,22)(H,23,24,25)/b17-8-/t5-,7-/m0/s1 |
| PubChem CID | 5742832 |
| Target Point | Bacterial |
| Passage | Anti-infection |
| Background | It is a monocyclic β-lactam antibiotic with high affinity for penicillin-binding protein 3 (PBP-3). |
| Biological Activity | Aztreonam (also known as SQ 26776) is a synthetic monocyclic beta-lactam antibiotic, used to treat Gram-negative aerobic bacteria infection. It has a very high affinity for penicillin-binding protein 3 (PBP-3). Aztreonam causes significant suppression of human colony forming unit-erythroid (cfu-e), burst forming unit-erythroid (bfu-e) and colony forming unit-granulocyte macrophage (cfu-gm) at both peak and trough serum concentrations in human bone marrow cells. Aztreonam is hydrolyzed at measurable rates by class A beta-lactamases, a TEM-2 type penicillinase and the Proteus vulgaris cephalosporinase with a broad substraterange.[1-3] |
| Data Literature Source | [1]. Kobayashi Y，et al. Synergy with aztreonam and arbekacin or tobramycin against Pseudomonas aeruginosa isolated from blood. J Antimicrob Chemother. 1992 Dec;30(6):871-2. [2]. Guay DR，et al. Aztreonam，a new monobactam antimicrobial. Clin Pharm. 1985 Sep-Oct;4(5):516-26. [3]. Ohmori S，et al. Pharmacology，994，48(3)，137-142. |
| Unit | Bottle |
| Specification | 10mg 10mM*1mL in DMSO 50mg 100mg |
Remark：These protocols are for reference only. Solarbio does not independently validate these methods.
Note：
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.
Co-Occurrence of the blaKPC-2 and Mcr-3.3 Gene in Aeromonas caviae SCAc2001 Isolated from Patients with Diarrheal Disease
Click to check >>Author：TangL;HuangJ;SheJ;ZhaoK;ZhouY
IF：3.8430
Publish_to：Infect Drug Resist
PMID：32547122
In Vitro Antimicrobial Susceptibility Differences Between Carbapenem-Resistant KPC-2-Producing and NDM-1-Producing Klebsiella pneumoniae in a Teaching Hospital in Northeast China.
Click to check >>Author：Lin L; Xiao X; Wang X; Xia M; Liu S.
IF：3.2150
Publish_to：Microb Drug Resist
PMID：31433255
Manual Download
